Harish Shantharam - 22 May 2023 Form 4 Insider Report for CymaBay Therapeutics, Inc.

Role
Chief Financial Officer
Signature
/s/ Paul Quinlan, as attorney-in-fact for Harish Shantharam
Issuer symbol
N/A
Transactions as of
22 May 2023
Net transactions value
$0
Form type
4
Filing time
22 May 2023, 17:13:34 UTC
Next filing
26 Jan 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CBAY Employee Stock Option (right to buy) Award $0 +360,000 $0.000000 360,000 22 May 2023 Common Stock 360,000 $8.76 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to 1/4 of the underlying shares on May 22, 2024 and vests as to 1/48 of the underlying shares monthly thereafter.